26 Jun 2017 | Cashinbis
With drug overdoses now the leading cause of death among Americans under the age of 50, public health officials are scampering to find solutions to address the current opioid epidemic.
26 Jun 2017 | Leafly
An Israeli company will partner with an Australian one to help boost clinical education opportunities around medical cannabis.
26 Jun 2017 | Fin Feed
Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc.
25 Jun 2017 | New York Daily News
The state Department of Health is boosting New York's medical marijuana program to meet growing demand. Effective immediately, doctors, nurse practitioners and physician assistants can register online and certify patients the same day.
24 Jun 2017 | News Medical
A study presented at the Congress of the European Academy of Neurology in Amsterdam confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.
24 Jun 2017 | The Guardian
Australia’s first doctors’ workshop on the medical uses of cannabis has heard about the complex situation around its legality. The Melbourne conference was held with the hope of improving the medical profession’s awareness about the issue.
23 Jun 2017 | Reuters
A handful of drugmakers are taking their first steps toward developing marijuana-based painkillers, alternatives to opioids that have led to widespread abuse and caused the U.S. health regulator to ask for a withdrawal of a popular drug this month.
23 Jun 2017 | Yahoo7 News
Poland's lower house of parliament, which is controlled by the conservatives, on Thursday voted to make medicinal marijuana legal under certain circumstances.
22 Jun 2017 | Stock News Now
Cannabis Science, Inc., a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its new product-development plans are well underway with the release of the first batch of the CBIS Transdermal Patch.
22 Jun 2017 | Market Wired
NEMUS Bioscience announced that tetrahydrocannabinol (THC) derived from NB1111, achieved significant tissue concentrations in multiple compartments of the eye that correlated with the lowering of IOP in a normotensive ocular animal model.